LOCALLY MANUFACTURED AUTOLOGOUS CD19 CHIMERIC ANTIGEN RECEPTOR-T (CAR-T) CELLS FOR PHASE II PROSPECTIVE CLINICAL TRIAL FOR RELAPSED/REFRACTORY B-ACUTE LYMPHOBLASTIC LEUKAEMIA IN MALAYSIA

被引：0
|
作者：
Lim, T. S. [1 ]
Nyunt, W. [1 ]
Then, K. [2 ]
Cheong, S. [2 ]
Then, K. [2 ]
Ooi, G. [2 ]
Govindasamy, V. [2 ]
Idris, M. Mohd [3 ]
Azura, S. [3 ]
Abdullah, N. [3 ]
Zakaria, M. Muhd [3 ,4 ]
Chang, A. H. [6 ]
Ithnin, A. [7 ]
Wahid, S. S. Abdul [3 ,5 ]
机构：
[1] Plutonet Sdn Bhd, Cyberjaya, Malaysia
[2] Cryocord Sdn Bhd, Cyberjaya, Malaysia
[3] Hosp Canselor Tuanku Muhriz Univ Kebangsaan Malay, Pusat Terapi Sel PTS, Kuala Lumpur, Malaysia
[4] Prince Court Med Ctr, Kuala Lumpur, Malaysia
[5] Hosp Canselor Tuanku Muhriz Univ Kebangsaan Malay, Dept Med, Fac Med, Kuala Lumpur, Malaysia
[6] Shanghai YaKe Biotechnol Ltd, Shanghai, Peoples R China
[7] Hosp Canselor Tuanku Muhriz Univ Kebangsaan Malay, Dept Pathol, Kuala Lumpur, Malaysia
来源：
CYTOTHERAPY | 2023年 / 25卷 / 06期
关键词：
CAR-T therapy; CAR-T manufacturing;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
1028
引用
收藏
页码：S225 / S226
页数：2
相关论文
共 50 条
  • [41] Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
    Wei, Guoqing
    Ding, Lijuan
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [42] CD4+CD25+CD127low regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia
    Pan, Ying
    Wang, Huiping
    An, Furun
    Wu, Fan
    Tao, Qianshan
    Li, Yingwei
    Ruan, Yanjie
    Zhai, Zhimin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [43] CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives
    Mohamad Mohty
    Jordan Gautier
    Florent Malard
    Mahmoud Aljurf
    Ali Bazarbachi
    Christian Chabannon
    Mohamed A. Kharfan-Dabaja
    Bipin N. Savani
    He Huang
    Saad Kenderian
    Arnon Nagler
    Miguel-Angel Perales
    Leukemia, 2019, 33 : 2767 - 2778
  • [44] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Yiyun Wang
    Yingying Yang
    Ruimin Hong
    Houli Zhao
    Guoqing Wei
    Wenjun Wu
    Huijun Xu
    Jiazhen Cui
    Yanlei Zhang
    Alex H. Chang
    Yongxian Hu
    He Huang
    Blood Cancer Journal, 10
  • [45] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Wang, Yiyun
    Yang, Yingying
    Hong, Ruimin
    Zhao, Houli
    Wei, Guoqing
    Wu, Wenjun
    Xu, Huijun
    Cui, Jiazhen
    Zhang, Yanlei
    Chang, Alex H.
    Hu, Yongxian
    Huang, He
    BLOOD CANCER JOURNAL, 2020, 10 (10)
  • [46] Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells
    Xu, Qianwen
    Xue, Lei
    An, Furun
    Xu, Hui
    Wang, Li
    Geng, Liangquan
    Zhang, Xuhan
    Song, Kaidi
    Yao, Wen
    Wan, Xiang
    Tong, Juan
    Liu, Huilan
    Liu, Xin
    Zhu, Xiaoyu
    Zhai, Zhimin
    Sun, Zimin
    Wang, Xingbing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Targeting CD19-Negative Relapsed B-Acute Lymphoblastic Leukemia Using Trivalent CAR T Cells
    Fousek, Kristen
    Watanabe, Junji
    George, Ann
    Byrd, Tiara
    An, Xingyue
    Samaha, Hebatalla
    Salsman, Vita
    Navai, Shoba
    Jang, Albert
    Kim, Hye Na
    Joseph, Sujith
    Baker, Matthew
    Varadarajan, Navin
    Hegde, Meenakshi
    Kim, Yong-Mi
    Heisterkamp, Nora
    Abdel-Azim, Hisham
    Ahmed, Nabil
    MOLECULAR THERAPY, 2018, 26 (05) : 298 - 298
  • [48] T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
    Lee, Daniel W.
    Kochenderfer, James N.
    Stetler-Stevenson, Maryalice
    Cui, Yongzhi K.
    Delbrook, Cindy
    Feldman, Steven A.
    Fry, Terry J.
    Orentas, Rimas
    Sabatino, Marianna
    Shah, Nirali N.
    Steinberg, Seth M.
    Stroncek, Dave
    Tschemia, Nick
    Yuan, Constance
    Zhang, Hua
    Zhang, Ling
    Rosenberg, Steven A.
    Wayne, Alan S.
    Mackall, Crystal L.
    LANCET, 2015, 385 (9967): : 517 - 528
  • [49] Long-term safety and activity of humanized CD19 chimeric antigen receptor T cells for children and young adults with relapsed/refractory acute lymphoblastic leukemia
    王诗媛
    China Medical Abstracts(Internal Medicine), 2022, 39 (04) : 231 - 232
  • [50] Two Ways of Targeting a CD19 Positive Relapse of Acute Lymphoblastic Leukaemia after Anti-CD19 CAR-T Cells
    Grain, Audrey
    Ollier, Jocelyn
    Guillaume, Thierry
    Chevallier, Patrice
    Le Calvez, Baptiste
    Eveillard, Marion
    Clemenceau, Beatrice
    BIOMEDICINES, 2023, 11 (02)
12345